share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  12/04 21:02

Moomoo AI 已提取核心信息

On December 3, 2024, 180 Life Sciences appointed Stephen H. Shoemaker to its Board of Directors, following the resignation of Omar Jimenez. Mr. Shoemaker, a seasoned executive with extensive experience in finance and strategic planning, will serve as a Class I director until the 2025 Annual Meeting.Mr. Shoemaker's appointment strengthens the Board's independence and compliance with Nasdaq's Listing Rule 5605(c)(2). He brings expertise in the gaming and eSports sectors, having previously led WIN Group and Engine Media Holdings. His strategic insights are expected to support 180's pivot into the entertainment and iGaming sectors.Mr. Jimenez will continue as CFO, focusing on financial leadership. The company anticipates leveraging Mr. Shoemaker's experience to drive growth and capitalize on new market opportunities.
On December 3, 2024, 180 Life Sciences appointed Stephen H. Shoemaker to its Board of Directors, following the resignation of Omar Jimenez. Mr. Shoemaker, a seasoned executive with extensive experience in finance and strategic planning, will serve as a Class I director until the 2025 Annual Meeting.Mr. Shoemaker's appointment strengthens the Board's independence and compliance with Nasdaq's Listing Rule 5605(c)(2). He brings expertise in the gaming and eSports sectors, having previously led WIN Group and Engine Media Holdings. His strategic insights are expected to support 180's pivot into the entertainment and iGaming sectors.Mr. Jimenez will continue as CFO, focusing on financial leadership. The company anticipates leveraging Mr. Shoemaker's experience to drive growth and capitalize on new market opportunities.
2024 年 12 月 3 日,在 Omar Jimenez 辞职后,180 Life Sciences 任命 Stephen H. Shoemaker 为董事会成员。舒梅克先生是一位经验丰富的高管,在财务和战略规划方面拥有丰富的经验,他将在2025年年会之前担任一级董事。Shoemaker先生的任命加强了董事会的独立性以及对纳斯达克上市规则5605(c)(2)的遵守情况。他带来了游戏和电子竞技领域的专业知识,此前曾领导过WIN集团和Engine Media Holdings。他的战略见解预计将支持180年代向娱乐和电子博彩领域的转型。希门尼斯将继续担任首席财务官,专注于财务领导力。该公司预计将利用Shoemaker先生的经验来推动增长并利用新的市场机会。
2024 年 12 月 3 日,在 Omar Jimenez 辞职后,180 Life Sciences 任命 Stephen H. Shoemaker 为董事会成员。舒梅克先生是一位经验丰富的高管,在财务和战略规划方面拥有丰富的经验,他将在2025年年会之前担任一级董事。Shoemaker先生的任命加强了董事会的独立性以及对纳斯达克上市规则5605(c)(2)的遵守情况。他带来了游戏和电子竞技领域的专业知识,此前曾领导过WIN集团和Engine Media Holdings。他的战略见解预计将支持180年代向娱乐和电子博彩领域的转型。希门尼斯将继续担任首席财务官,专注于财务领导力。该公司预计将利用Shoemaker先生的经验来推动增长并利用新的市场机会。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息